Uncover key drivers, emerging technologies, and competitive movements shaping the rare disease genetic testing market from 2026–2035 with trusted insights from The Business Research Company
By how much is the Rare Disease Genetic Testing Market expected to grow between 2026 and 2030?
The rare disease genetic testing market size has witnessed substantial growth in recent years. It is forecast to grow from $1.17 billion in 2025 to $1.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.7%. This historical expansion can be attributed to enhancements in genomic sequencing technologies, the proliferation of rare disease research initiatives, increased awareness regarding genetic disorders, the establishment of specialized diagnostic laboratories, and the development of clinical genetics programs.
The rare disease genetic testing market is projected for substantial growth in the coming years, with its valuation expected to reach $2.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period is fueled by factors such as the escalating demand for personalized medicine, increased investments in genomic data analytics, the broader adoption of population-scale genetic screening, the deeper integration of genetics into routine clinical care, and advancements in bioinformatics platforms. Significant trends anticipated for this period include the wider acceptance of next-generation sequencing for rare diseases, the growing application of AI-driven variant interpretation, the enlargement of comprehensive genetic testing panels, the increasing incorporation of genetic data into clinical decision systems, and a heightened emphasis on early and accurate diagnosis.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27404&type=smp
Which Drivers Are Influencing Market Acceleration In The Rare Disease Genetic Testing Market?
A projected rise in genetic disorders is anticipated to fuel the expansion of the rare disease genetic testing market in the future. These conditions stem from DNA irregularities in individuals, which can be passed down from parents or emerge as novel mutations. The rise in genetic disorders is linked to an increase in parental age, given that older parents face a greater likelihood of transmitting genetic mutations to their offspring. Rare disease genetic testing aids in diagnosing genetic disorders by pinpointing specific mutations, thus allowing for precise and prompt identification. This testing facilitates personalized treatment plans, thereby improving patient care and boosting long-term health outcomes. For example, data from May 2024, released by the National Health Service, a UK government department, indicates that 17,000 individuals are currently living with sickle cell disease, an inherited genetic blood disorder, and approximately 250 new diagnoses occur annually. Consequently, the growing prevalence of genetic disorders is a key impetus for the expansion of the rare disease genetic testing market.
What Segments Are Identified Within The Structure Of The Rare Disease Genetic Testing Market?
The rare disease genetic testing market covered in this report is segmented –
1) By Disease Type: Immunological Disorders, Cardiovascular Disorders, Neurological Disease, Endocrine And Metabolism Disorders Diseases, Hematological Diseases, Dermatological Disease, Other Disease Types
2) By Technology: Next-Generation Sequencing, Sanger Sequencing, Polymerase Chain Reaction Based Testing, Array Based Testing, Fluorescence In Situ Hybridization, Other Technologies
3) By Specialty: Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests
4) By End-User: Hospitals And Clinics, Research Laboratories And Contract Research Organizations, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Immunological Disorders: Autoimmune Disorders, Allergic Conditions, Primary Immunodeficiency Disorders, Inflammatory Disorders
2) By Cardiovascular Disorders: Congenital Heart Defects, Cardiomyopathies, Aortic Aneurysms, Pulmonary Hypertension
3) By Neurological Disease: Neurodegenerative Disorders, Neuromuscular Disorders, Epileptic Syndromes, Movement Disorders
4) By Endocrine And Metabolism Disorders Diseases: Inherited Metabolic Disorders, Thyroid Disorders, Adrenal Disorders, Diabetes Related Genetic Conditions
5) By Hematological Diseases: Hemophilia, Thalassemia, Sickle Cell Disease, Clotting Disorders
6) By Dermatological Disease: Genetic Skin Disorders, Connective Tissue Disorders, Pigmentary Disorders, Keratinization Disorders
7) By Other Disease Types: Skeletal Dysplasia, Renal Genetic Disorders, Ophthalmic Genetic Conditions, Gastrointestinal Genetic Conditions
How Are New Market Trends Shaping The Landscape Of The Rare Disease Genetic Testing Market?
Major companies operating in the rare disease genetic testing market are strategically focusing on the development of technologically advanced solutions, such as digital genomics platforms, to significantly improve the speed, precision, and scalability of rare disease diagnosis. These digital genomics platforms are sophisticated software systems that seamlessly integrate genomic data analysis, interpretation, and reporting, thereby streamlining and accelerating the entire genetic testing and diagnosis process. For instance, in March 2025, Strand Life Sciences Private Limited, an India-based computer software company, introduced its StrandOmics Portal, a digital platform designed to boost the efficiency and accuracy of rare disease diagnosis. The portal provides clinicians with comprehensive insights into genetic variants, facilitating faster and more precise diagnoses. It offers support for advanced variant interpretation, including applications in prenatal diagnostics, and enables independent reviews of genetic data. This introduction clearly demonstrates a robust commitment to advancing precision medicine and equipping healthcare professionals with effective tools to enhance patient outcomes.
Which Key Players Are Driving Competition In The Rare Disease Genetic Testing Market?
Major companies operating in the rare disease genetic testing market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Natera Inc., OPKO Health Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BioReference Laboratories Inc., Invitae Corporation, Ambry Genetics Corporation, Centogene N.V., Baylor Genetics Company, PreventionGenetics, Blueprint Genetics Oy, Artemis DNA Inc., BGI Genomics Co. Ltd., GeneDx Inc., Genomics England Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/rare-disease-genetic-testing-global-market-report
Which Region Is Projected To Lead The Rare Disease Genetic Testing Market During The Forecast Period?
North America was the largest region in the rare disease genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Rare Disease Genetic Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27404&type=smp
Browse Through More Reports Similar to the Global Rare Disease Genetic Testing Market 2026, By The Business Research Company
Datafication Market Report 2026
https://www.thebusinessresearchcompany.com/report/datafication-global-market-report
Alternative Data Market Report 2026
https://www.thebusinessresearchcompany.com/report/alternative-data-global-market-report
Data Catalog Market Report 2026
https://www.thebusinessresearchcompany.com/report/data-catalog-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model